Theratechnologies Files 6-K, Reports Press Release
| Field | Detail |
|---|---|
| Company | Theratechnologies Inc. |
| Form Type | 6-K |
| Filed Date | Apr 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing-update, press-release
TL;DR
Theratechnologies filed a 6-K on April 16th, check their press release from April 15th for news.
AI Summary
Theratechnologies Inc. filed a Form 6-K on April 16, 2025, reporting a press release dated April 15, 2025. The filing indicates the company is a foreign private issuer and will file its annual reports under Form 20-F. The press release details are not included in the provided text.
Why It Matters
This filing serves as an update for investors regarding the company's reporting status and upcoming disclosures, potentially including significant business or financial news.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain specific financial results or material events that would inherently increase risk.
Key Players & Entities
- Theratechnologies Inc. (company) — Registrant
- Jocelyn Lafond (person) — General Counsel and Corporate Secretary
- April 15, 2025 (date) — Press Release Date
- April 16, 2025 (date) — Filing Date
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report a press release dated April 15, 2025, and to confirm Theratechnologies Inc.'s status as a foreign private issuer filing under Form 20-F.
What is the filing date of this report?
This report was filed on April 16, 2025.
Which exhibit is included with this filing?
Exhibit 99.1, a Press Release Dated April 15, 2025, is included with this filing.
Who signed this report on behalf of Theratechnologies Inc.?
Jocelyn Lafond, General Counsel and Corporate Secretary, signed this report on behalf of Theratechnologies Inc.
What is the principal executive office address of Theratechnologies Inc.?
The principal executive office address is 2015 Peel Street, Suite 1100, Montreal, Quebec H3A 1T8, Canada.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 16, 2025 by Jocelyn Lafond regarding Theratechnologies Inc..